Kiniksa Pharmaceuticals
KNSA
#4646
Rank
C$2.10 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
$28.95
Share price
-6.43%
Change (1 day)
18.34%
Change (1 year)

Kiniksa Pharmaceuticals (KNSA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$0.20 Billion

According to Kiniksa Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kiniksa Pharmaceuticals - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.20 B75.76%
2023-12-31C$0.11 B34.61%
2022-12-31C$86.19 M41.61%
2021-12-31C$60.87 M27.21%
2020-12-31C$47.85 M25.86%
2019-12-31C$38.02 M-34.63%
2018-12-31C$58.16 M-66.28%
2017-12-31C$0.17 B56.16%
2016-12-31C$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$44.1 M-78.17%๐Ÿ‡บ๐Ÿ‡ธ USA